KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Idexx Laboratories (IDXX) Equity Ratio (2016 - 2025)

Historic Equity Ratio for Idexx Laboratories (IDXX) over the last 17 years, with Q3 2025 value amounting to 0.46.

  • Idexx Laboratories' Equity Ratio fell 453.87% to 0.46 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.46, marking a year-over-year decrease of 453.87%. This contributed to the annual value of 0.48 for FY2024, which is 636.88% up from last year.
  • As of Q3 2025, Idexx Laboratories' Equity Ratio stood at 0.46, which was down 453.87% from 0.44 recorded in Q2 2025.
  • Idexx Laboratories' Equity Ratio's 5-year high stood at 0.48 during Q4 2024, with a 5-year trough of 0.18 in Q2 2022.
  • Over the past 5 years, Idexx Laboratories' median Equity Ratio value was 0.38 (recorded in 2023), while the average stood at 0.36.
  • In the last 5 years, Idexx Laboratories' Equity Ratio skyrocketed by 42760.51% in 2021 and then plummeted by 4349.0% in 2022.
  • Idexx Laboratories' Equity Ratio (Quarter) stood at 0.28 in 2021, then dropped by 21.72% to 0.22 in 2022, then soared by 105.48% to 0.46 in 2023, then grew by 6.37% to 0.48 in 2024, then decreased by 4.83% to 0.46 in 2025.
  • Its last three reported values are 0.46 in Q3 2025, 0.44 for Q2 2025, and 0.45 during Q1 2025.